Lobular breast carcinoma usually shows poor responsiveness to chemotherapies and often lacks targeted therapies. Since FGFR1 expression has been shown to play pivotal roles in primary breast cancer tumorigenesis, we sought to analyze the status of FGFR1 gene in a metastatic setting of lobular breast carcinoma, since promising FGFR1 inhibitors has been recently developed.

FGFR-1 amplification in metastatic lymph-nodal and haematogenous lobular breast carcinoma.

BRUNELLI, Matteo;Caliò A;MANFRIN, Erminia;NOTTEGAR, Alessia;Bria, Emilio;TORTORA, GIAMPAOLO;PEDRON, Serena;CHILOSI, Marco;ZAMBONI, Giuseppe;MARTIGNONI, Guido;BONETTI, Franco
2012

Abstract

Lobular breast carcinoma usually shows poor responsiveness to chemotherapies and often lacks targeted therapies. Since FGFR1 expression has been shown to play pivotal roles in primary breast cancer tumorigenesis, we sought to analyze the status of FGFR1 gene in a metastatic setting of lobular breast carcinoma, since promising FGFR1 inhibitors has been recently developed.
Lobular breast carcinoma; FGFR1 expression; FGFR1 inhibitors
File in questo prodotto:
File Dimensione Formato  
FGFR1.pdf

solo utenti autorizzati

Tipologia: Versione dell'editore
Licenza: Accesso ristretto
Dimensione 668.83 kB
Formato Adobe PDF
668.83 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11562/493150
Citazioni
  • ???jsp.display-item.citation.pmc??? 18
  • Scopus 38
  • ???jsp.display-item.citation.isi??? 35
social impact